Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (191-200 of 421) with videos related to

Pageof 43
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 23, 2021
Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysisLucia Caiano, Marc Carrier, Andrea Marshall, et al.
Journal of Thrombosis and Haemostasis : JTH|August 3, 2023
Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapyDanielle Carole Roy, Tzu-Fei Wang, Marc Carrier, et al.
Thrombosis Research|September 17, 2013
Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysisSiavash Piran, Grégoire Le Gal, Philip S Wells, et al.
Thrombosis Research|October 29, 2021
Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysisAllen Li, Willem Brandt, Cameron Brown, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 2, 2010
Should we screen patients with unprovoked venous thromboembolism for occult cancers? A pilot studyMarc Carrier, Grégoire Le Gal, Hardy Tao, et al.
Pilot and Feasibility Studies|June 2, 2020
Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndromeKimberly Legault, Mark Blostein, Marc Carrier, et al.
Plos One|November 10, 2018
A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-makingAmy Johnston, Shu-Ching Hsieh, Marc Carrier, et al.
The Bone & Joint Journal|February 1, 2021
Effect of oral anticoagulant use on surgical delay and mortality in hip fractureDaniel You, Yan Xu, Brett Ponich, et al.
Thrombosis Research|August 17, 2021
Media portrayals of pulmonary embolismShannon M Fernando, Rebecca Mathew, Laveena Munshi, et al.
Pilot and Feasibility Studies|April 30, 2020
A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndromeKimberly Legault, Mark Blostein, Marc Carrier, et al.
Pageof 43

Showing results (191-200 of 421) with videos related to

Sort By:
Pageof 43
Journal of Thrombosis and Haemostasis : JTH|June 23, 2021
Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysisLucia Caiano, Marc Carrier, Andrea Marshall, et al.
Journal of Thrombosis and Haemostasis : JTH|August 3, 2023
Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapyDanielle Carole Roy, Tzu-Fei Wang, Marc Carrier, et al.
Thrombosis Research|September 17, 2013
Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysisSiavash Piran, Grégoire Le Gal, Philip S Wells, et al.
Thrombosis Research|October 29, 2021
Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysisAllen Li, Willem Brandt, Cameron Brown, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 2, 2010
Should we screen patients with unprovoked venous thromboembolism for occult cancers? A pilot studyMarc Carrier, Grégoire Le Gal, Hardy Tao, et al.
Pilot and Feasibility Studies|June 2, 2020
Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndromeKimberly Legault, Mark Blostein, Marc Carrier, et al.
Plos One|November 10, 2018
A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-makingAmy Johnston, Shu-Ching Hsieh, Marc Carrier, et al.
The Bone & Joint Journal|February 1, 2021
Effect of oral anticoagulant use on surgical delay and mortality in hip fractureDaniel You, Yan Xu, Brett Ponich, et al.
Thrombosis Research|August 17, 2021
Media portrayals of pulmonary embolismShannon M Fernando, Rebecca Mathew, Laveena Munshi, et al.
Pilot and Feasibility Studies|April 30, 2020
A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndromeKimberly Legault, Mark Blostein, Marc Carrier, et al.
Pageof 43